Church v. Biden

CourtDistrict Court, District of Columbia
DecidedMay 11, 2022
DocketCivil Action No. 2021-2815
StatusPublished

This text of Church v. Biden (Church v. Biden) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Church v. Biden, (D.D.C. 2022).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

STEVEN CHURCH, et al., Plaintiffs, v. Civil Action No. 21-2815 (CKK) JOSEPH R. BIDEN, in his official capacity as President of the United States, et al., Defendants.

MEMORANDUM OPINION (May 11, 2022)

The plaintiffs in this case include eighteen federal civilian employees (“Federal Employee

Plaintiffs”) 1 and two active-duty Marines (“Service Member Plaintiffs”) 2 (collectively,

“Plaintiffs”). By virtue of their federal civilian and military employment, Plaintiffs are subject to

the COVID-19 vaccine mandates imposed under Executive Order 14043 and Secretary of Defense

Lloyd Austin’s August 24, 2021 order for the vaccination of military personnel. Plaintiffs claim

that the vaccination requirements imposed by these orders infringe on their religious freedoms

under the First Amendment and the Religious Freedom Restoration Act (“RFRA”). 3

Pending before the Court is Defendants’ [23] Motion to Dismiss. Upon consideration of

the pleadings, the relevant legal authorities, and the record as a whole, 4 the Court concludes that it

1 The “Federal Employee Plaintiffs” are: Steven Church, Lesley Church, Alma Gonzalez, Dynika Barnwell, Douglas Czerwinski, Jason Coffey, Joshua Schmidt, Melina Royer, Tamika Walls, Jaime Espitia, Somer Stephens, Alex Berne, Alan Camp, Stephanie Perrotta, Christopher Axtell, Grace Brown, Kristofor Hallfrisch, and Dorothy Morgan. 2 The “Service Member Plaintiffs” are: First Lieutenant Andrew Soto and Corporal Christopher Hall. 3 Plaintiffs have voluntarily dismissed Counts 3 and 4 of their Complaint, which challenge these vaccine mandates under the Food, Drug, and Cosmetic Act (“FDCA”) and Equal Protection clause of the Fifth Amendment. See Pls.’ Opp’n at 3.4 The Court’s consideration has focused on the following: Defendants’ Memorandum of Law in Support of Defendants’ Motion to Dismiss (“Defs.’ Mot.”), ECF No. 23; Plaintiffs’ Memorandum of Law in Opposition to Defendants’ Motion to Dismiss (“Pls.’ Opp’n”), ECF No. 27; and Reply Memorandum of Law in Support of Defendants’ Motion to Dismiss (“Defs.’ Reply”), ECF No. 28. In an exercise of its discretion, the Court finds that holding oral argument in this action would not be of assistance in rendering a decision. See LCvR 7(f). 4 The Court’s consideration has focused on the following: Defendants’ Memorandum of Law in Support of Defendants’ Motion to Dismiss (“Defs.’ Mot.”), ECF No. 23; Plaintiffs’ Memorandum of Law in Opposition to lacks jurisdiction over the Federal Employee Plaintiffs’ remaining claims and therefore GRANTS

IN PART Defendants’ [23] Motion to Dismiss and DISMISSES this case without prejudice as to

the Federal Employee Plaintiffs. The Court shall HOLD IN ABEYANCE Defendants’ [23]

Motion to Dismiss as to the Service Member Plaintiffs, and shall address those claims in a separate

Memorandum Opinion.

I. BACKGROUND

A. COVID-19 Pandemic & Vaccine Development

Coronavirus disease (“COVID-19”) is an infectious disease caused by the SARS-CoV-2

virus. 5 Spread principally by “exposure to respiratory fluids,” the “initial presentation of a

[COVID-19] infection ranges from no symptoms at all (asymptomatic) to severe illness and death;

and even after recovery, various long-term health problems may linger.” Klaasen v. Trustees of

Ind. Univ., --- F. Supp. 3d ---, 2021 WL 3073926, at *2 (N.D. Ind. July 18, 2021) (internal citations

omitted). 6 To date, approximately 46 million cases of COVID-19 have been reported in the United

States; the disease has claimed the lives of more than 995,000 Americans. 7

As another federal district court summarized, “COVID-19 caught the world unaware.

Initially, there were no vaccines or treatments[.]” Klaassen, 2021 WL 3073926, at *8. Shortly

after then-President Donald J. Trump declared a national emergency on March 13, 2020, see 85

Defendants’ Motion to Dismiss (“Pls.’ Opp’n”), ECF No. 27; and Reply Memorandum of Law in Support of Defendants’ Motion to Dismiss (“Defs.’ Reply”), ECF No. 28. In an exercise of its discretion, the Court finds that holding oral argument in this action would not be of assistance in rendering a decision. See LCvR 7(f). 5 World Health Org., Coronavirus disease (COVID-19), https://www.who.int/health-topics/coronavirus#tab=tab_1 (last visited May 11, 2022). 6 See also CDC, Scientific Brief: SARS-CoV2 Transmission, https://www.cdc.gov/coronavirus/2019- ncov/science/science-briefs/sars-cov-2-transmission.html (last visited May 11, 2022); CDC, People with Certain Medical Conditions, https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical- conditions html (last visited May 11, 2022). 7 See CDC, COVID-19 Data Tracker, https://covid.cdc.gov/covid-data-tracker/#cases_casesper100klast7days (last visited May 11, 2022).

2 Fed. Reg. 15,337 (Mar. 13, 2020), the Secretary of the U.S. Department of Health and Human

Services (“HHS”) determined that “circumstances exist justifying the authorization of emergency

use of drugs and biological products during the COVID-19 pandemic,” see 85 Fed. Reg. 18,250,

18,250–51 (Apr. 1, 2020). In such circumstances, the U.S. Food and Drug Administration

(“FDA”) may issue an “emergency use authorization” (“EUA”) for FDA-regulated products

“intended for use” in responding to the emergency before such products receive FDA “approval.”

See 21 U.S.C. § 360bbb-3(a)(1). In October 2020, the FDA issued guidance to vaccine developers,

“outlining [the FDA’s] expectations for vaccine sponsors,” including the “scientific data and

information” that would be required to obtain an EUA. 8

In late 2020 and early 2021, the FDA issued EUAs for COVID-19 vaccines developed by

three companies—Pfizer BioNTech, Moderna, and Johnson & Johnson.9 On August 23, 2021, the

FDA approved the vaccine created by Pfizer BioNTech, which would be marketed as “Comirnaty,”

for “the prevention of COVID-19 disease in individuals 16 years of age and older.” 10 On January

31, 2022, Moderna’s vaccine obtained FDA approval for its intended use by individuals aged 18

years and older. 11

8 See FDA, Coronavirus (COVID-19) CBER-Regulated Biologics, Emergency Use Authorization, https://www.fda.gov/vaccines-blood-biologics/industry-biologics/coronavirus-covid-19-cber-regulated-biologics (last visited May 11, 2022). The latest version of the FDA’s Industry Guidance was issued on May 25, 2021, superseding the original guidance issued in October 2020 and a second iteration dated February 22, 2021. See Emergency Use Authorization for Vaccines to Prevent COVID-19, Guidance for Industry (May 25, 2021), https://www.fda.gov/media/142749/download. 9 See FDA, Moderna COVID-19 Vaccine, https://www fda.gov/emergency-preparedness-and-response/coronavirus- disease-2019-covid-19/moderna-covid-19-vaccine (last visited May 11, 2022); FDA, Comirnaty and Pfizer-BioNTech COVID-19 Vaccine, https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid- 19/comirnaty-and-pfizer-biontech-covid-19-vaccine (last visited Nov. 8, 2021); FDA, Janssen COVID-19 Vaccine, https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19- vaccine (last visited May 11, 2022). 10 See FDA News Release, FDA Approves First COVID-19 Vaccine (Aug. 23, 2021), https://www.fda.gov/news- events/press-announcements/fda-approves-first-covid-19-vaccine. 11 See FDA, News Release, FDA Takes Key Action by Approving Second COVID-19 Vaccine (Jan.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Abbott Laboratories v. Gardner
387 U.S. 136 (Supreme Court, 1967)
Texas v. United States
523 U.S. 296 (Supreme Court, 1998)
Coalition for Underground Expansion v. Mineta
333 F.3d 193 (D.C. Circuit, 2003)
Sprint Corp. v. Federal Communications Commission
331 F.3d 952 (D.C. Circuit, 2003)
Settles v. United States Parole Commission
429 F.3d 1098 (D.C. Circuit, 2005)
National Treasury Employees Union v. United States
101 F.3d 1423 (D.C. Circuit, 1996)
Wright v. Foreign Service Grievance Board
503 F. Supp. 2d 163 (District of Columbia, 2007)
American Farm Bureau v. United States Environmental Protection Agency
121 F. Supp. 2d 84 (District of Columbia, 2000)
Finca Santa Elena, Inc. v. United States Army Corps of Engineers
873 F. Supp. 2d 363 (District of Columbia, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Church v. Biden, Counsel Stack Legal Research, https://law.counselstack.com/opinion/church-v-biden-dcd-2022.